Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Emerg Infect Dis ; 19(11): 1847-50, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24229563

ABSTRACT

During 2003-2012, 8 clusters of meningococcal disease were identified in Rio de Janeiro State, Brazil, all caused by serogroup C Neisseria meningitidis. The isolates were assigned to 3 clonal complexes (cc): cc11, cc32, and cc103. These hyperinvasive disease lineages were associated with endemic disease, outbreaks, and high case-fatality rates.


Subject(s)
Disease Outbreaks , Meningitis, Meningococcal/epidemiology , Neisseria meningitidis, Serogroup C/classification , Adolescent , Adult , Brazil/epidemiology , Child , Child, Preschool , Humans , Infant , Middle Aged , Multilocus Sequence Typing , Neisseria meningitidis, Serogroup C/genetics , Public Health Surveillance , Serotyping , Topography, Medical , Young Adult
4.
Emerg Infect Dis ; 18(8): 1336-8, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22840713

ABSTRACT

During the 1990s, an epidemic of B:4 Neisseria meningitidis infections affected Brazil. Subsequent increase in C:4 disease suggested B → C capsular switching. This study identified B → C switches within the sequence type 32 complex. Substantial disease related to capsular switching emphasizes the need for surveillance of circulating meningococcal strains to optimize disease control.


Subject(s)
Antigenic Variation/genetics , Bacterial Capsules/genetics , Epidemics , Neisseria meningitidis, Serogroup B/genetics , Neisseria meningitidis, Serogroup C/genetics , Adolescent , Adult , Brazil/epidemiology , Child , Child, Preschool , Female , Genotype , Humans , Infant , Male , Meningococcal Infections/epidemiology , Middle Aged , Multilocus Sequence Typing , Neisseria meningitidis, Serogroup B/classification , Neisseria meningitidis, Serogroup C/classification , Sequence Analysis, DNA , Serotyping , Young Adult
5.
Pediatr Infect Dis J ; 31(1): 30-6, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21860337

ABSTRACT

BACKGROUND: Here, we report a laboratory-based study of Streptococcus pneumoniae recovered from patients with meningitis in Rio de Janeiro State, Brazil. METHODS: The aim of this study was to determine the evolution of ß-lactam resistance, antimicrobial susceptibility pattern, serotypes, and genetic diversity of S. pneumoniae, isolated from meningitis patients between 2000 and 2008. RESULTS: A total of 264 S. pneumoniae recovered from patients between 2000 and 2008 were included. Susceptibility testing (E-test) of S. pneumoniae showed resistance to penicillin, ceftriaxone, oxacillin, cotrimoxazole, tetracycline, ofloxacin, erythromycin, chloramphenicol, and rifampicin. Penicillin resistance (PEN-R, minimal inhibitory concentration [MIC] ≥ 0.12 µg/mL) increased from 8% of isolates in 2000-2002, to 12% in 2003-2005, and to 20% in 2006-2008. Ceftriaxone resistance (MIC ≥ 1.0 µg/mL) was detected among some PEN-R isolates (13%) from 2004 onward. Within the PEN-R isolates, serotypes that are included in 10-valent pneumococcal conjugate vaccine predominated (90%), and resistance was detected mostly in isolates of serotypes 14 (61%), 23F (16%), 6B (10%), and 19F (3%). Multilocus sequence typing showed that 52% of the PEN-R isolates, and 89% of those with MICs ≥ 0.5 µg/mL, were sequence type (ST)-156 or single-locus variants of this ST (ST-557 or ST-4388); all of these isolates were serotype 14 and were assigned to the Spain-3 clone. CONCLUSIONS: ß-lactam resistance increased recently among cerebrospinal fluid isolates and was mainly due to the surge of the ST-4388, a previously undescribed gki single-locus variants of ST-156. Regional surveillance is shown to be essential to provide optimal antimicrobial therapy, monitor highly successful clones, and formulate adequate vaccination strategy.


Subject(s)
Genetic Variation , Meningitis, Pneumococcal/epidemiology , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/drug effects , beta-Lactam Resistance , Adolescent , Adult , Aged , Anti-Bacterial Agents/pharmacology , Brazil/epidemiology , Cerebrospinal Fluid/microbiology , Child , Child, Preschool , Female , Genotype , Humans , Infant , Male , Meningitis, Pneumococcal/microbiology , Microbial Sensitivity Tests , Middle Aged , Serotyping , Streptococcus pneumoniae/genetics , Streptococcus pneumoniae/isolation & purification , Young Adult
6.
Anaerobe ; 17(4): 156-60, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21669297

ABSTRACT

Clostridium difficile is the primary known cause of antibiotic-associated diarrhea. Diarrheal disease in food animals due to C. difficile infection has been well documented. Recently, reports of C. difficile infections in patients with no known risk factors for disease have raised concern of community acquisition through food animals and food. In this study, multi-locus variable number tandem repeat analysis (MLVA) was performed on a collection of 97C. difficile isolates of human, animal and food origin belonging to either the North American pulsed-field type (NAP) 1 or NAP7/NAP8. MLVA discriminated between NAP1 and NAP7/NAP8 populations. Three clusters of food, food animal and human NAP1 isolates were highly related by MLVA. These data suggest the possibility of either laboratory contamination or widespread distribution of clonal C. difficile populations. Community-associated NAP1 isolates were unrelated to NAP1 food and food animal isolates. Two MLVA loci were absent and 1 was invariant in all NAP7/NAP8 isolates. Therefore, MLVA discrimination was not sufficient to make assessments regarding the genetic associations among food, food animal and human isolates belonging to the NAP7/NAP8 pulsovar. Rigorous epidemiologic and laboratory investigations that employ highly discriminatory genotyping methods are necessary to compare C. difficile isolates from food and food animals to those from humans.


Subject(s)
Clostridioides difficile/genetics , Clostridium Infections/microbiology , Community-Acquired Infections/microbiology , Food Microbiology , Minisatellite Repeats , Alleles , Animals , Bacterial Typing Techniques/methods , Clostridioides difficile/isolation & purification , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Humans , Meat/microbiology
7.
Vaccine ; 29(35): 6049-58, 2011 Aug 11.
Article in English | MEDLINE | ID: mdl-21704667

ABSTRACT

Several meningococcal vaccines under development for prevention of serogroup B disease target the factor H-binding protein (FHbp), an immunogenic lipoprotein expressed on the surface of Neisseria meningitidis. Based upon sequence and phylogenetic analyses, FHbp can be classified into 3 protein variants (1, 2 or 3) or 2 subfamilies (A or B). The potential effect of FHbp-containing vaccines on meningococcal carriage is not known. We determined the diversity of FHbp among a population of carriage isolates obtained from Georgia and Maryland high school students in 1998 and 2006-2007. Analysis of the fHbp gene sequence from 408 carriage isolates identified 30 different FHbp protein sequences. The majority of carriage isolates harbored FHbp proteins belonging to variant 2/subfamily A. Association between FHbp proteins and genetic lineage was observed among the carriage isolates. However, split decomposition analysis, together with tests of linkage disequilibrium and pairwise homoplasy suggest recombination at fHbp contribute to allelic diversity. Of note, the FHbp proteins in serogroup B vaccines under development are either absent or not well represented in this carriage population. The FHbp genetic repertoire observed in carriage isolate populations will be useful in understanding the potential impact of FHbp-containing vaccines on meningococcal carriage.


Subject(s)
Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Carrier State/microbiology , Genetic Variation , Meningococcal Infections/microbiology , Neisseria meningitidis/isolation & purification , Adolescent , Georgia , Humans , Maryland , Meningococcal Infections/prevention & control , Meningococcal Vaccines , Neisseria meningitidis/classification , Neisseria meningitidis/genetics , Recombination, Genetic , Serotyping
SELECTION OF CITATIONS
SEARCH DETAIL
...